Chronic hand eczema (CHE) is one of the most persistent inflammatory skin conditions in adults. About one-third of patients suffer from moderate to severe hand eczema. The treatment of CHE aims to provide long-term relief of symptoms so that patients can achieve a good quality of life and resume their normal daily activities. Many of those affected either do not respond adequately to topical steroids (TCS) or experience side effects with prolonged use. Therefore, for long-term management, it is advisable to use a well-tolerated, effective steroid-free option.
You May Also Like
- Acute nonspecific back pain
Implementing a biopsychosocial approach
- Neuropathic Pain
Evidence-Based Neuromodulation Based on Clinical Trials and Real-World Data
- Psychedelic-assisted therapy
Current status of PAT
- Fibromyalgia Syndrome
Development, Diagnosis, Epidemiology, and Treatment of a Disease Entity
- Juvenile Idiopathic Arthritis
Early Detection and Targeted Treatment in an Interdisciplinary Setting
- Innovative Oral Treatment Options for Psoriasis: Icotrokinra and Zasocitinib
First-class immunomodulation combined with convenience—the data available so far is convincing
- Chronic hand eczema: common, long-lasting, and distressing
Non-steroidal anti-inflammatory treatment options are essential for long-term management
- Disorders of the Gut-Brain Interaction